3.94
2.07%
0.08
Handel nachbörslich:
4.43
0.49
+12.44%
Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
10.36%
109.98
|
99.65 | 108.53 | 117.32 | 107.64 |
Cost Of Revenue |
3.34%
28.70
|
27.77 | 25.79 | 26.32 | 26.61 |
Gross Profit |
13.07%
81.28
|
71.88 | 82.74 | 91.00 | 81.03 |
Operating Expenses
|
16.38%
85.13
|
73.15 | 74.69 | 81.25 | 85.04 |
Interest Income/Expense |
2.39%
0.514
|
0.502 | 0.444 | 0.594 | 0.649 |
Benefits Costs and Expenses |
12.69%
114.32
|
101.45 | 100.89 | 108.14 | 112.27 |
Costs And Expenses |
12.69%
114.32
|
101.45 | 100.89 | 108.14 | 112.27 |
Operating Income/Loss |
203.55%
-3.852
|
-1.269 | 8.05 | 9.745 | -4.001 |
Nonoperating Income/Loss |
6.83%
-0.491
|
-0.527 | -0.413 | -0.566 | -0.626 |
Income/Loss From Continuing Operations Before Tax |
141.82%
-4.343
|
-1.796 | 7.637 | 9.179 | -4.627 |
Income Tax Expense/Benefit |
82.65%
-2.243
|
-1.228 | 4.47 | 3.863 | -1.658 |
Income/Loss From Continuing Operations After Tax |
269.72%
-2.10
|
-0.568 | 3.167 | 5.316 | -2.969 |
Net Income/Loss
|
269.72%
-2.10
|
-0.568 | 3.167 | 5.316 | -2.969 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
30.31M%
131.86
|
0.000435 | 131.31 | 131.29 | 131.08 |
Diluted Average Shares |
302.75K%
131.86
|
-0.0436 | 133.42 | 133.07 | 131.08 |
Basic Earnings Per Share |
-0.02
|
- | 0.02 | 0.04 | -0.02 |
Diluted Earnings Per Share |
-0.02
|
- | 0.02 | 0.04 | -0.02 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):